Referencias

1. Early Breast Cancer Trialists' Collaborative Group. Treatment of carly breast cancer. Worldwideevidence 1985-1990. Oxford, Oxford University Press.
2. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med. 1995 Nov 30;333(22):1444-55. | CrossRef | PubMed
3. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998 Feb;16(2):441-52. | PubMed
4. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al, Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997 Oct 2;337(14):949-55. | CrossRef | PubMed
5. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Post-operative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82e randomised trial, Lancet. 1999 May 15;353(9165):1641-8. | CrossRef | PubMed
6. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in nodepositive premenopausal women wíth breast N Engl J Med. 1997 Oct 2;337(14):956-62. | CrossRef | PubMed
7. Auquier A, Rutqvist LE, Høst H, Rotstein S, Arriagada R. Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trials. Eur J Cancer. 1992;28(2-3):433-7. | CrossRef | PubMed
8. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 1995 Dec;13(12):2869-78. | PubMed
9. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 1995 Dec;13(12):2869-78. | PubMed
10. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy, J Clin Oncol. 1994 Mar;12(3):447-53. | PubMed
11. Rutqvist LE, Lax I, Fornander T, Johansson H. et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22(5):887-96. | CrossRef | PubMed
12. Arriagada R, Rutqvist LE, Lê MG. Postmastectomy radiotherapy: randomized trials. Semin Radiat Oncol. 1999 Jul;9(3):275-86. | CrossRef | PubMed
13. Sauer R, Tulusan AH, Lang N, et al. Can breast irradiation be omitted in low-risk breast cancer patients after segmentectomy: first results of the Erlangen protocol. Int J Radiat Oncol Biol Phys 1993; 27 (suppl 1): 146-147 (abstract). | CrossRef
14. Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage 1 breast cancer. Cancer. 1996 Mar 15;77(6):1094-100. | CrossRef | PubMed
15. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992 May 6;84(9):683-9. | CrossRef | PubMed
16. Liljegren G, Karlsson G, Bergh J, Holmberg L. The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage 1. Results from a randomized trial. Ann Oncol. 1997 Aug;8(8):757-63. | CrossRef | PubMed
17. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987 Jan;71(1):15-29. | PubMed
18. Høst H, Brennhovd IO, Loeb M. Post-operative radiotherapy in breast cancer: Longterm results from the Oslo study. Int J Radiat Oncol Biol Phys. 1986 May;12(5):727-32. | CrossRef | PubMed
19. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet. 1998 Jul 25;352(9124):257-63. | CrossRef | PubMed
20. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. “Role of a 10 Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997 Mar;15(3):963-8. | PubMed
21. Bartelink H, Horiot J C, Van der Schueren E. et al. “Is a boost dose essential in breast conserving therapy? An EORTC phase 111 study”, Radiother Oncol. 1977 43 (Suppl 2): S23. | CrossRef
22. Dewar JA, Sarrazin D, Benhamou E, Petit JY, Benhamou S, Arriagada R, et al. Management of the axilla in conservativelytreated breast cancer: 592 patients treated at the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):475-81. | PubMed
23. Falk SJ. Radiotherapy and the management of the axilla in carly breast cancer. Br J Surg. 1994 Sep;81(9):1277-81. | CrossRef | PubMed
24. Leonard C, Corkill M, Tompkin J, Zhen B, Waitz D, Norton L, et al. Are axillary recurrence and overall survival affected by axíllary extranodal tumor extension in breast cancer? Implications for radiation therapy. J Clin Oncol. 1995 Jan;13(1):47-53. | PubMed
25. Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy? Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9. | CrossRef | PubMed
26. Fletcher G H. Textbook of Radiotherapy. 3 dEditíon, Lea & Febiger, 1980
27. Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G. Radiotherapy alone in breast cancer: 1 Analysis of tumor parameters, tumor dose and local control: The experience of the Gustave-Roussy Institute and The Princess Margaret Hospital. Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1751-7. | CrossRef | PubMed
28. Denham JW. The radiation dose-response relationship for control of primary breast cancer. Radiother Oncol. 1986 Oct;7(2):107-23. | CrossRef | PubMed
29. Dutreix J, Tubiana M, Dutreix A. An approach to the interpretation of clinical data on the tumour control probability dose relationship. Radiother Oncol. 1988 Mar;11(3):239-48. | CrossRef | PubMed
30. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early stage breast cancer. N Engl J Med. 1996 May 23;334(21):1356-61. | CrossRef | PubMed
31. Harris J R, Morrow M. Local management of invasive breast cancer,En: Diseases of the Breast. Phlladelphia, Lippincot-Raven Publ, 1996, 487-547.
32. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetie outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol. 1992 Mar;10(3):356-63. | PubMed
33. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst. 1996 Jul 3;88(13):918-22. | CrossRef | PubMed